These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 3855482

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Soft agar colony formation of bladder cells during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine and application to detection of bladder cancer promoters.
    Hashimura T, Kanamaru H, Yoshida O.
    Jpn J Cancer Res; 1987 May; 78(5):473-9. PubMed ID: 3112059
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T, Asamoto M, Toriyama-Baba H, Yamamoto F, Matsuoka Y, Ochiya T, Sekiya T, Terada M, Akaza H, Tsuda H.
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [Abstract] [Full Text] [Related]

  • 25. Promoting effect of sodium o-phenylphenate and o-phenylphenol on two-stage urinary bladder carcinogenesis in rats.
    Fukushima S, Kurata Y, Shibata M, Ikawa E, Ito N.
    Gan; 1983 Oct; 74(5):625-32. PubMed ID: 6642136
    [Abstract] [Full Text] [Related]

  • 26. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
    Tsuda H, Miyata Y, Murasaki G, Kinoshita H, Fukushima S.
    Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292
    [No Abstract] [Full Text] [Related]

  • 27. [Effect of cis-diamminedichloroplatinum (II) (CDDP) on bladder cancer on rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)].
    Miyakawa M, Yoshida O.
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):258-62. PubMed ID: 6820893
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
    Miyata Y, Tsuda H, Matayoshi-Miyasato K, Fukushima S, Murasaki G, Ogiso T, Ito N.
    Gan; 1978 Dec; 69(6):845-8. PubMed ID: 750276
    [Abstract] [Full Text] [Related]

  • 30. Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors.
    Grubbs CJ, Juliana MM, Eto I, Casebolt T, Whitaker LM, Canfield GJ, Manczak M, Steele VE, Kelloff GJ.
    Anticancer Res; 1993 Dec; 13(1):33-6. PubMed ID: 8476227
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Squamous and transitional elements in rat bladder carcinomas induced by N-butyl-N-4-hydroxybutyl-nitrosamine (BBN). A study of cytokeratin expression.
    Herman CJ, Vegt PD, Debruyne FM, Vooijs GP, Ramaekers FC.
    Am J Pathol; 1985 Sep; 120(3):419-26. PubMed ID: 2412446
    [Abstract] [Full Text] [Related]

  • 33. [Histological study of urinary bladder tumor: DNA of rat urinary bladder tumor caused by N-butyl-N-(4-hydroxybutyl) nitrosamine and that of human bladder tumor].
    Murase T, Kobayashi O, Aota Y, Mitsuta H, Koshikawa T.
    Hinyokika Kiyo; 1983 Mar; 29(3):303-10. PubMed ID: 6677123
    [Abstract] [Full Text] [Related]

  • 34. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T, Shirai T, Takahashi S, Mutai M, Fukushima S.
    Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
    [Abstract] [Full Text] [Related]

  • 35. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice.
    Irving CC, Murphy WM, Daniel DS.
    J Natl Cancer Inst; 1984 Sep; 73(3):753-6. PubMed ID: 6590920
    [Abstract] [Full Text] [Related]

  • 36. [Animal models of bladder cancer].
    Fukushima S.
    Hinyokika Kiyo; 1988 Nov; 34(11):1923-7. PubMed ID: 3242366
    [Abstract] [Full Text] [Related]

  • 37. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
    Miyata Y, Fukushima S, Hirose M, Masui T, Ito N.
    Jpn J Cancer Res; 1985 Sep; 76(9):828-34. PubMed ID: 3932281
    [Abstract] [Full Text] [Related]

  • 38. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 39. Cataracts in rats given a bladder carcinogen, N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Fujita J, Yoshida O, Fujita H, Mikuni I.
    Tokai J Exp Clin Med; 1983 Nov; 8(4):359-63. PubMed ID: 6679940
    [Abstract] [Full Text] [Related]

  • 40. Effect of simultaneous administration of leupeptin on induction of bladder tumors in rats by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Kakizoe T, Matsukura N, Aoyagi M, Kawachi T, Sugimura T.
    Gan; 1980 Feb; 71(1):138-40. PubMed ID: 7380132
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.